SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 28, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $316K total
Actionable Insight • Neutral

This insider cluster is routine and non-informative. The CEO's large derivative exercise followed by immediate sales is a standard cashless exercise pattern for tax purposes. Monitor for any material changes in fundamentals (next earnings, pipeline updates) but this filing alone does not warrant a trading action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$510.38
T+0 close · Aug 28, 2026 · via day close
Latest settled
−5.66%
T+20 · $481.47 · next T+60 in 7d
Vs SPY
−5.29%
α at T+20
Latest observation
+16.99%
T+53 · FF3 residual α
  1. T+0 · Aug 31 $510.38entry
  2. T+1 · 3mo ago +0.45%α +1.14% · $512.70
  3. T+5 · 2mo ago −2.43%α −2.29% · $497.97
  4. T+20 · 7w ago −5.66%α −5.29% · $481.47
  5. T+54 · todayOpen
  6. T+60 · in 7d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Martine Rothblatt executed a large derivative exercise of 9,500 shares at $135.42, then immediately sold the resulting shares plus additional holdings in 20 open-market transactions on August 27, 2026, totaling ~$5.9M in sales. EVP & General Counsel Paul Mahon also sold 120 shares for $63K on August 20. The CEO's sales are consistent with a cashless exercise-and-sell pattern (tax withholding and liquidity), not a directional bearish signal. At $22.6B market cap, the total open-market sales of ~$316K (cluster) represent ~0.0014% of market cap, trivial and routine.

Key Financial Metrics

Direction
selling
Total Value
$316.0K
Insiders
2

Key Facts

  • CEO Martine Rothblatt exercised 9,500 derivative shares at $135.42 ($1.29M intrinsic value) and sold a total of ~11,000 shares across 20 trades on Aug 27, 2026, netting ~$5.9M in proceeds
  • EVP & General Counsel Paul Mahon sold 120 shares for ~$63K on Aug 20, 2026
  • Total open-market sales in the cluster: ~$316K, representing ~0.0014% of $22.6B market cap
  • The CEO's sales are consistent with a cashless exercise-and-sell pattern, not a directional bearish signal
  • No other insiders (CFO, COO, directors) participated in selling during the window

Financial Impact

Total insider sales of ~$316K (cluster) are trivial relative to $22.6B market cap

insider ownership

Risk Factors

  • CEO sold a large absolute dollar amount (~$5.9M) which could be misinterpreted as bearish by retail traders

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1787983293318

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (10h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 29, 2026